Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

The approval of the first oncolytic virus for the treatment of metastatic melanoma and the compiling evidence that the use of oncolytic viruses can enhance cancer immunotherapies targeted against various immune checkpoint proteins has attracted great interest in the field of cancer virotherapy. We h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Erkko Ylösmäki, Cristina Malorzo, Cristian Capasso, Oona Honkasalo, Manlio Fusciello, Beatriz Martins, Leena Ylösmäki, Antti Louna, Sara Feola, Henrik Paavilainen, Karita Peltonen, Veijo Hukkanen, Tapani Viitala, Vincenzo Cerullo
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Acesso em linha:https://doi.org/10.1016/j.ymthe.2018.06.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!